Dynamic change of tetraspanin CD151 membrane protein expression in colorectal cancer patients.
To measure the CD151 expression in colorectal cancer (CRC). CD151 expression was assessed in 179 CRC patients and 39 patients with hepatic liver metastasis. High CD151 expression was observed in 48% of patients with early-stage CRC versus only 33% of patients with metastatic colon cancer. A higher level of tumor invasion status correlated with a decrease in CD151 expression. Metastatic stage and advanced tumor stage correlated with a decreased CD151 expression. Twenty-seven out of the 39-paired samples had high CD151 expression in liver metastasis sites. CD151 expression is decreased in patients with metastatic CRC.